Philip Morris International upgraded by Argus
$PM
Medicinal Chemicals and Botanical Products
Health Care
Argus upgraded Philip Morris International from Hold to Buy
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/22/2026 | $216.00 | Buy | BTIG Research |
| 1/20/2026 | $180.00 | Buy → Hold | Jefferies |
| 7/9/2025 | $220.00 | Buy | Jefferies |
| 5/22/2025 | $195.00 | Buy | Needham |
| 4/25/2025 | $170.00 | Sell → Neutral | UBS |
| 3/14/2025 | Hold → Buy | Argus | |
| 1/16/2025 | $140.00 | Overweight | Morgan Stanley |
| 3/5/2024 | Buy → Hold | Argus |
Second-Quarter Reported Diluted EPS declined by 7.7% to $1.80; Adjusted Diluted EPS grew by 15.2% to $2.20; and by 13.6% excluding currency; Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2026 second quarter results.1 "We delivered outstanding results in the second quarter, driving net revenues to over $11 billion for the first time with excellent growth across all headline metrics," said Jacek Olczak, Group CEO PMI. "With a robust first half under our belt, including continued momentum and strong results in our smoke-free business, we are well positioned to deliver on our full-year targets while investing for future growth." _______________
Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live audio webcast on Wednesday, July 22, 2026, at 9:00 a.m. ET, to discuss its 2026 second-quarter and first six-months financial results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast can be accessed here. The webcast will be hosted by Emmanuel Babeau, Group Chief Financial Officer, and Massimo Andolina, incoming Group CFO, and will include discussion of PMI’s financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI’s Investor Relations App at www.pmi.com
Featuring original designs from acclaimed artists, the nationwide initiative celebrates America's 250th anniversary through collectible metal ZYN cases STAMFORD, Conn., July 3, 2026 /PRNewswire/ -- Philip Morris International's U.S. businesses (PMI U.S.) today announced the launch of the ZYN America250 Art Series, a cultural initiative from America's No. 1 nicotine pouch brand, celebrating the nation's 250th anniversary through the lens of contemporary American art and creative expression. The ZYN America250 Art Series brings together a curated group of American and U.S.-based a
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
4 - Philip Morris International Inc. (0001413329) (Issuer)
8-K - Philip Morris International Inc. (0001413329) (Filer)
8-K - Philip Morris International Inc. (0001413329) (Filer)
8-K - Philip Morris International Inc. (0001413329) (Filer)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)
BTIG Research initiated coverage of Philip Morris International with a rating of Buy and set a new price target of $216.00
Jefferies downgraded Philip Morris International from Buy to Hold and set a new price target of $180.00
Jefferies resumed coverage of Philip Morris International with a rating of Buy and set a new price target of $220.00
Second-Quarter Reported Diluted EPS declined by 7.7% to $1.80; Adjusted Diluted EPS grew by 15.2% to $2.20; and by 13.6% excluding currency; Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2026 second quarter results.1 "We delivered outstanding results in the second quarter, driving net revenues to over $11 billion for the first time with excellent growth across all headline metrics," said Jacek Olczak, Group CEO PMI. "With a robust first half under our belt, including continued momentum and strong results in our smoke-free business, we are well positioned to deliver on our full-year targets while investing for future growth." _______________
Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on July 20, 2026, to shareholders of record as of June 25, 2026. The ex-dividend date is June 25, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily cons
Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, will address investors today at the 2026 dbAccess Global Consumer Conference in Paris at 11:15 a.m. CET (5:15 a.m. ET), including discussion of the following topics: PMI's continued expectation of a strong full-year performance, notably driven by the broad-based momentum of our international multicategory smoke-free business, led by IQOS. Recent heat-not-burn category developments broadly in-line with our expectations, most notably in Japan following the April 1, 2026 excise tax increase, with April offtake impacted by consumer pantry de-loading and IQOS maintaining a strong category sh
Intern class doubles to 25, signaling expanded investment in early-career talent STAMFORD, Conn., May 18, 2026 /PRNewswire/ -- Today, Philip Morris International's U.S. business (PMI U.S.) announced expanded internship and early‑career programs across the organization, underscoring its commitment to developing the next generation of talent to grow the business and innovate its industry. The programs are designed to provide meaningful experience, exposure, and opportunity for students just beginning their careers and early-career professionals ready to accelerate their impact. This summer, PMI U.S. will welcome its second intern
The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta
Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex